BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30217523)

  • 1. Pneumococcal vaccination in adult solid organ transplant recipients: A review of current evidence.
    Dendle C; Stuart RL; Mulley WR; Holdsworth SR
    Vaccine; 2018 Oct; 36(42):6253-6261. PubMed ID: 30217523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in adult liver transplant recipients.
    Eriksson M; Käyhty H; Lahdenkari M; Mäkisalo H; Anttila VJ
    Vaccine; 2021 Apr; 39(17):2351-2359. PubMed ID: 33812743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroresponses and safety of 13-valent pneumococcal conjugate vaccination in kidney transplant recipients.
    Dendle C; Stuart RL; Polkinghorne KR; Balloch A; Kanellis J; Ling J; Kummrow M; Moore C; Thursky K; Buttery J; Mulholland K; Gan PY; Holdsworth S; Mulley WR
    Transpl Infect Dis; 2018 Apr; 20(2):e12866. PubMed ID: 29512234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal immunity and PCV13 vaccine response in SOT-candidates and recipients.
    Blanchard-Rohner G; Enriquez N; Lemaître B; Cadau G; Giostra E; Hadaya K; Meyer P; Gasche-Soccal PM; Berney T; van Delden C; Siegrist CA
    Vaccine; 2021 Jun; 39(26):3459-3466. PubMed ID: 34023135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, single blind, controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in renal transplant recipients.
    Tobudic S; Plunger V; Sunder-Plassmann G; Riegersperger M; Burgmann H
    PLoS One; 2012; 7(9):e46133. PubMed ID: 23029408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
    Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
    Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era.
    Olarte L; Lin PL; Barson WJ; Romero JR; Tan TQ; Givner LB; Hoffman JA; Bradley JS; Hultén KG; Mason EO; Kaplan SL
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27862712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients.
    Lin PL; Michaels MG; Green M; Mazariegos GV; Webber SA; Lawrence KS; Iurlano K; Greenberg DP
    Pediatrics; 2005 Jul; 116(1):160-7. PubMed ID: 15995047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia.
    Gidding HF; McCallum L; Fathima P; Moore HC; Snelling TL; Blyth CC; Jayasinghe S; Giele C; de Klerk N; Andrews RM; McIntyre PB;
    Vaccine; 2018 May; 36(19):2650-2656. PubMed ID: 29627233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
    Ingels HA
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
    Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
    Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults.
    Chalmers JD; Campling J; Dicker A; Woodhead M; Madhava H
    BMC Pulm Med; 2016 May; 16(1):77. PubMed ID: 27169895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions.
    Cho BH; Stoecker C; Link-Gelles R; Moore MR
    Vaccine; 2013 Dec; 31(50):6011-21. PubMed ID: 24148572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.
    Lee KY; Tsai MS; Kuo KC; Tsai JC; Sun HY; Cheng AC; Chang SY; Lee CH; Hung CC
    Hum Vaccin Immunother; 2014; 10(12):3700-10. PubMed ID: 25483681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of pneumococcal conjugate vaccines on the incidence of invasive pneumococcal disease caused by ten non-vaccine serotypes in Denmark.
    Slotved HC; Dalby T; Hoffmann S
    Vaccine; 2016 Feb; 34(6):769-74. PubMed ID: 26772630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in adult liver transplant recipients.
    Kumar D; Chen MH; Wong G; Cobos I; Welsh B; Siegal D; Humar A
    Clin Infect Dis; 2008 Oct; 47(7):885-92. PubMed ID: 18715160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of different vaccine schedules for heptavalent and 13-valent conjugate vaccines against pneumococcal disease in the Community of Madrid.
    Latasa P; Ordobás M; Garrido-Estepa M; Gil de Miguel A; Sanz JC; Barranco MD; Insúa E; García-Comas L
    Vaccine; 2017 Sep; 35(40):5381-5387. PubMed ID: 28807606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study.
    Domínguez Á; Ciruela P; Hernández S; García-García JJ; Soldevila N; Izquierdo C; Moraga-Llop F; Díaz A; F de Sevilla M; González-Peris S; Campins M; Uriona S; Martínez-Osorio J; Solé-Ribalta A; Codina G; Esteva C; Planes AM; Muñoz-Almagro C; Salleras L
    PLoS One; 2017; 12(8):e0183191. PubMed ID: 28806737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.
    Lepoutre A; Varon E; Georges S; Dorléans F; Janoir C; Gutmann L; Lévy-Bruhl D; ;
    Vaccine; 2015 Jan; 33(2):359-66. PubMed ID: 25448105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal conjugate vaccine for young children.
    Selman S; Hayes D; Perin LA; Hayes WS
    Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.